Elevance Health Inc. ($ELV) Stock Forecast: Down 2.1% Today

What is Elevance Health Inc.?

Elevance Health (NYSE: ELV) has demonstrated strong performance over the past 20 years, surpassing the market with an average annual return of 9.7%.

Why is Elevance Health Inc. going down?

ELV stock is down 2.1% on Feb 12, 2025 16:26

• Despite its historical outperformance, ELV recently saw a notable bearish movement in its stock price.
• The decline in ELV's stock price may be attributed to profit-taking by investors following a prolonged growth period.
• Market sentiment may have changed due to factors such as macroeconomic conditions or specific company events.
• Investors could be reassessing their positions in ELV, leading to the observed bearish movement.

ELV Price Chart

ELV Technical Analysis

ELV News

If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today - Elevance Health ( NYSE:ELV )

Elevance Health ELV has outperformed the market over the past 20 years by 1.31% on an annualized basis producing an average annual return of 9.7%. Currently, Elevance Health has a market capitalization of $90.56 billion.

https://www.benzinga.com/insights/news/25/02/43546751/if-you-invested-1000-in-this-stock-20-years-ago-you-would-have-this-much-today

Trending Today

Memecoin ($MEME) Crypto Forecast: Up 7.7% Today

Maker ($MKR) Crypto Forecast: Up 6.0% Today

Ethena ($ENA) Crypto Forecast: Down 5.6% Today

Movement ($MOVE) Crypto Forecast: Up 5.1% Today

MANTRA ($OM) Crypto Forecast: Up 5.3% Today

Sonic (prev. FTM) ($S) Crypto Forecast: Down 5.2% Today

Ethereum ($ETH) Crypto Forecast: Up 5.0% Today

Toncoin ($TON) Crypto Forecast: Up 5.0% Today

Pepe ($PEPE) Crypto Forecast: Up 6.4% Today

dogwifhat ($WIF) Crypto Forecast: Up 9.8% Today

Elevance Health Inc. Price History

17.09.2024 - ELV Stock was down 15.3%

• Elevance Health's Q3 earnings disappointed, as profits were below estimates due to issues with medical costs, resulting in a pessimistic market sentiment.
• While the company had a history of surpassing earnings expectations, the latest quarterly results fell short, leading to a drop in the stock price.
• Concerns about Elevance Health's less optimistic annual forecast may be influencing the market's reaction, suggesting possible obstacles for the company in the future.
• Investors who had gained substantial profits over the past decade may be capitalizing on their returns, contributing to today's bearish movement in the stock.

17.09.2024 - ELV Stock was down 12.6%

• ELV reported third-quarter revenues that beat expectations, driven by higher premium yields and product revenue growth, but the stock still experienced a bearish movement.
• The profit falling short of expectations and issuing a soft annual outlook may have contributed to investor concerns and selling pressure on the stock.
• Despite the recent underperformance, ELV has a history of beating earnings estimates, which could indicate potential volatility in the stock price based on future reports.
• The stock's impressive long-term performance, with a significant increase in value over the past decade, may have attracted profit-taking from investors leading to the bearish movement today.

18.09.2024 - ELV Stock was up 5.7%

• ELV posted third-quarter revenues of $44.7 billion, surpassing predictions and demonstrating a 5.3% year-over-year growth, driven by increased premium yields in the Health Benefits segment and CarelonRx product revenue expansion.
• Despite the favorable revenue uptick, ELV's earnings were negatively impacted by reduced Medicaid and Medicare memberships, resulting in an earnings shortfall compared to expectations.
• The market responded positively to the revenue outperformance but exhibited some caution in light of the earnings miss and subdued annual forecast, leading to fluctuations in the stock's price.
• Investors are currently pondering whether ELV will exceed estimates in the upcoming earnings release, reflecting sustained intrigue and uncertainty concerning the company's performance.

04.08.2024 - ELV Stock was down 4.6%

• Despite being highlighted as one of the best stocks to buy, ELV faced a significant decline in its market value.
• The bearish movement could be attributed to potential profit-taking by investors who may have previously bought into the stock based on recommendations.
• It's essential for investors to conduct thorough research and not solely rely on external recommendations, as market dynamics can quickly change, leading to unexpected downturns in stock prices.

15.09.2024 - ELV Stock was down 5.0%

• Today's bearish trend in ELV could be attributed to investors' cautious approach in anticipation of the company's Q3 earnings announcement.
• Despite forecasts of increased operating income from the Carelon business, there may be apprehensions about ELV's ability to meet Wall Street's projections for key performance indicators.
• The absence of the necessary elements for a probable earnings surpass, alluded to previously, may have influenced the downward pressure on ELV's stock.
• Investors could be stepping back to review their holdings in ELV, considering uncertainties surrounding the imminent earnings update.

23.00.2025 - ELV Stock was up 3.2%

• Elevance Health (ELV) experienced a notable upward trend today attributed to favorable developments and market optimism.
• Despite a decline in medical membership, the company showed a profitable Q4 and raised its dividend by 5%.
• Operational revenue saw a substantial increase due to enhanced risk-based functionalities and recent acquisitions.
• Q4 earnings and revenues surpassed expectations, indicating a promising future for the stock.
• The stock's upward trajectory could be linked to expectations of robust Q4 earnings, despite potential worries over increased expenses.

13.05.2024 - ELV Stock was up 2.0%

• The bullish movement in ELV stock could be attributed to the positive earnings outlook projected for 2024, indicating strong growth potential for the company.
• Investor optimism following the company's communication about their earnings outlook may have contributed to the upward movement in the stock price.
• The market's positive reaction to the news of Elevance Health's future earnings could have driven increased buying interest and pushed the stock price higher.

31.04.2024 - ELV Stock was up 5.0%

• ELV stock saw a bullish uptrend today, potentially due to its participation in the Goldman Sachs 45th Annual Global Healthcare Conference.
• Being recognized as a top choice by Baird in the managed care sector, alongside other healthcare firms, might have also played a role in the positive market performance.
• ELV's consistent long-term market outperformance, with an average annual return of 17.09% over 15 years, likely appealed to investors seeking steady growth prospects.
• The general optimism towards healthcare stocks, reflected in Cigna Group's rising RS rating, may have additionally bolstered investor confidence in ELV's future growth potential.

17.06.2024 - ELV Stock was down 5.1%

• ELV surpassed expectations for earnings and revenue in Q2 but saw a significant drop in market value.
• The market's reaction to ELV's strong quarterly performance may be linked to concerns about its future growth potential.
• Investor attention may have shifted to factors like guidance and general market trends, contributing to the downward trend.
• The decrease in ELV's stock price following positive financial results could be attributed to profit-taking or broader market sentiment.

17.06.2024 - ELV Stock was down 6.0%

• ELV stock declined despite beating earnings and revenue estimates, driven by a decrease in Medicaid membership, raising concerns about future growth.
• Investors seemed disappointed by the slight year-over-year decline in second-quarter revenues, even though they surpassed consensus expectations.
• The market response emphasized the focus on the Medicaid membership drop and its potential impact on the company's future, overshadowing the positive earnings beat.
• The contrasting signals from the earnings beat and membership decline underscore the need to consider all aspects of a company's performance in evaluating stock movement.

17.06.2024 - ELV Stock was down 5.9%

• Despite Elevance Health surpassing earnings expectations and reiterating its yearly guidance, the stock faced a downward trend.
• Market response to indicators of escalating medical expenditures and reduced Medicaid enrollment prompted investor wariness regarding the company's future earnings.
• The robust growth in product revenue within the Carelon sector and reduced benefit expenses were overshadowed by apprehensions about the company's financial prospects, leading to its stock decline.
• Investors could be adopting a more cautious approach towards Elevance Health due to uncertainties concerning its profitability sustainability amidst escalating costs and membership attrition.

12.01.2025 - ELV Stock was down 2.1%

• Despite its historical outperformance, ELV recently saw a notable bearish movement in its stock price.
• The decline in ELV's stock price may be attributed to profit-taking by investors following a prolonged growth period.
• Market sentiment may have changed due to factors such as macroeconomic conditions or specific company events.
• Investors could be reassessing their positions in ELV, leading to the observed bearish movement.